BNP Paribas Financial Markets’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39
Closed -$85 6066
2025
Q4
$85 Hold
39
﹤0.01% 5623
2025
Q3
$215 Buy
39
+3
+8% +$23 ﹤0.01% 5389
2025
Q2
$270 Hold
36
﹤0.01% 5265
2025
Q1
$236 Sell
36
-310
-90% -$3.66K ﹤0.01% 5197
2024
Q4
$4.55K Sell
346
-963
-74% -$9.91K ﹤0.01% 4943
2024
Q3
$7.43K Buy
1,309
+884
+208% +$5.87K ﹤0.01% 3816
2024
Q2
$2.5K Buy
+425
New +$3.8K ﹤0.01% 3802
2022
Q4
Sell
-565
Closed -$56.8K 4491
2022
Q3
$56.8K Buy
+565
New +$65.8K ﹤0.01% 3956

Other funds holding RBOT

BNP Paribas Financial Markets's RBOT Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 39 shares — an estimated $85 sold.

BNP Paribas Financial Markets first reported a position in RBOT in Q3 2022 and held it in 8 quarters. The position peaked at $56.8K in Q3 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 39 Vicarious Surgical shares in Q1 2026, an estimated $85.
  • BNP Paribas Financial Markets first reported a position in Vicarious Surgical in Q3 2022 and held it in 8 quarters.
  • BNP Paribas Financial Markets's Vicarious Surgical position peaked at $56.8K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.